These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 28257998)
1. The battle of "nano" paclitaxel. Sofias AM; Dunne M; Storm G; Allen C Adv Drug Deliv Rev; 2017 Dec; 122():20-30. PubMed ID: 28257998 [TBL] [Abstract][Full Text] [Related]
2. Nanopaclitaxel therapy: an evidence based review on the battle for next-generation formulation challenges. Barkat MA; Beg S; Pottoo FH; Ahmad FJ Nanomedicine (Lond); 2019 May; 14(10):1323-1341. PubMed ID: 31124758 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®. Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929 [TBL] [Abstract][Full Text] [Related]
4. Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers. Gawde KA; Sau S; Tatiparti K; Kashaw SK; Mehrmohammadi M; Azmi AS; Iyer AK Colloids Surf B Biointerfaces; 2018 Jul; 167():8-19. PubMed ID: 29625422 [TBL] [Abstract][Full Text] [Related]
5. Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane. Feng Z; Zhao G; Yu L; Gough D; Howell SB Cancer Chemother Pharmacol; 2010 Apr; 65(5):923-30. PubMed ID: 19685054 [TBL] [Abstract][Full Text] [Related]
6. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer. Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666 [TBL] [Abstract][Full Text] [Related]
8. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391 [TBL] [Abstract][Full Text] [Related]
9. Novel Water-Borne Polyurethane Nanomicelles for Cancer Chemotherapy: Higher Efficiency of Folate Receptors Than TRAIL Receptors in a Cancerous Balb/C Mouse Model. Ajorlou E; Khosroushahi AY; Yeganeh H Pharm Res; 2016 Jun; 33(6):1426-39. PubMed ID: 26908046 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation. Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630 [TBL] [Abstract][Full Text] [Related]
11. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery. Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978 [TBL] [Abstract][Full Text] [Related]
12. Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy. Wang F; Porter M; Konstantopoulos A; Zhang P; Cui H J Control Release; 2017 Dec; 267():100-118. PubMed ID: 28958854 [TBL] [Abstract][Full Text] [Related]
13. Biological evaluation of PEG modified nanosuspensions based on human serum albumin for tumor targeted delivery of paclitaxel. Yin T; Cai H; Liu J; Cui B; Wang L; Yin L; Zhou J; Huo M Eur J Pharm Sci; 2016 Feb; 83():79-87. PubMed ID: 26699227 [TBL] [Abstract][Full Text] [Related]
14. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo. Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098 [TBL] [Abstract][Full Text] [Related]
15. Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors. Ye J; Liu Y; Xia X; Meng L; Dong W; Wang R; Fu Z; Liu H; Han R Oncol Rep; 2016 Jul; 36(1):399-409. PubMed ID: 27175803 [TBL] [Abstract][Full Text] [Related]
16. Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity. Lin Z; Gao W; Hu H; Ma K; He B; Dai W; Wang X; Wang J; Zhang X; Zhang Q J Control Release; 2014 Jan; 174():161-70. PubMed ID: 24512789 [TBL] [Abstract][Full Text] [Related]
20. A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy. Shan L; Cui S; Du C; Wan S; Qian Z; Achilefu S; Gu Y Biomaterials; 2012 Jan; 33(1):146-62. PubMed ID: 21959006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]